Literature DB >> 2019989

Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects.

R W Foltin1, M W Fischman.   

Abstract

Ten healthy adult male research volunteers with histories of smoked and i.v. cocaine use participated in four daily sessions. After resting base line, subjects received the same cocaine dose twice with a 14-min interval between doses. Cocaine hydrochloride (16 and 32 mg) was injected or cocaine base (25 and 50 mg) was smoked. Heart rate, blood pressure, subjective effects and venous blood were sampled repeatedly. The potency of smoked cocaine was about 60% of that of i.v. cocaine, i.e., a 50-mg dose of smoked cocaine had effects similar to a 32-mg dose of i.v. cocaine. Cocaine plasma level increased after each dose up to 425 ng/ml with peaks observed 4 min after the second dose. Plasma levels 44 min after the first dose were similar to plasma levels seen 4 min after the first dose. Smoked and i.v. cocaine produced similar increases in heart rate, blood pressure and rate pressure product at similar cocaine venous plasma levels. VAS ratings of "stimulated" and "high" were greater at similar plasma levels after smoked cocaine compared to i.v. cocaine. In addition VAS ratings of cocaine "liking" were also greater for smoked than i.v. cocaine. Otherwise the subjective effects of smoked and i.v. cocaine were similar. The effects of specific cocaine plasma levels on cardiovascular activity and some subjective reports were diminished across the session, demonstrating the development of acute tolerance to cocaine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019989

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  46 in total

1.  Cocaine: history, use, abuse.

Authors:  S B Karch
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

2.  Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys.

Authors:  C W Bradberry; R L Barrett-Larimore; P Jatlow; S R Rubino
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

Authors:  C W Bradberry
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

4.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

Review 5.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

6.  Methamphetamine self-administration in humans during D-amphetamine maintenance.

Authors:  Erika Pike; William W Stoops; Lon R Hays; Paul E A Glaser; Craig R Rush
Journal:  J Clin Psychopharmacol       Date:  2014-12       Impact factor: 3.153

7.  Disulfiram effects on responses to intravenous cocaine administration.

Authors:  Jennifer R Baker; Peter Jatlow; Elinore F McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

8.  Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Erik W Gunderson; Heather M Haughey; Xin-Qun Wang; Lei Liu
Journal:  Addict Biol       Date:  2012-10-08       Impact factor: 4.280

9.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

10.  Determining the subjective and physiological effects of BZP on human females.

Authors:  Joanne C Lin; Nisha Bangs; Heeseung Lee; Rob R Kydd; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.